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70Low rates of complications for carotid artery
stenting are associated with a high clinician volume
of carotid artery stenting and aortic endografting
but not with a high volume of percutaneous
coronary interventions
J. Gregory Modrall, MD,a Jayer Chung, MD,a Melissa L. Kirkwood, MD,a M. Shadman Baig, MD,a,b
Shirling X. Tsai, MD,a,b Carlos H. Timaran, MD,a R. James Valentine, MD,a and Eric B. Rosero, MD, MS,c
Dallas, Tex
Objective: Prior studies have demonstrated improved clinical outcomes for surgeons with a high-volume experience with
certain open vascular operations. A high-volume experience with carotid artery stenting (CAS) improves clinical out-
comes. Moreover, it is not known whether experience with other endovascular procedures, including percutaneous
coronary interventions (PCIs), is an adequate substitute for experience with CAS. The goal of this study was to quantify
the effect of increasing clinician volume of CAS, endovascular aneurysm repair (EVAR), and thoracic endovascular aortic
aneurysm repair (TEVAR), and PCI on the outcomes for CAS.
Methods: The Nationwide Inpatient Sample was analyzed to identify patients undergoing CAS for the years 2005 to
2009. Clinicians were stratiﬁed into tertiles of low-volume, medium-volume, and high-volume groups by annual volume
of CAS, EVAR/TEVAR, and PCI. Multiple logistic regression analyses were used to examine the relationship between
clinician volume and a composite outcome of the in-hospital stroke and death rate after CAS.
Results: Between 2005 and 2009, 56,374 elective CAS procedures were performed nationwide, with a crude in-hospital stroke
anddeath rate of 3.22%.Amedian of nineCASprocedures (interquartile range, 3-20)wereperformed annually per clinician.As
expected, stroke and death rates for CAS decreased with increasing volume of CAS performed by a clinician (low-volume vs
medium-volume vs high-volume: 4.43% vs 2.89% vs 2.27%;P[ .0001). Similar patternswerenoted between clinicians’ volume
of EVAR/TEVAR (low-volume vs medium-volume vs high-volume: 4.58% vs 3.18% vs 2.16%; P [ .0023). In contrast,
increasing PCI volume was not associated with decreased stroke and death rates after CAS (low-volume vs medium-volume vs
high-volume:2.99%vs3.18%vs3.55%;P[ .35).After adjustingforpatientandhospital characteristics, clinicianvolumeofCAS
(oddsratio [OR],0.84;95%conﬁdence interval [CI],0.74-0.94;P[ .003)andEVAR/TEVAR(OR,0.85;95%CI,0.75-0.97;
P [ .020) remained signiﬁcant predictors of stroke and death after CAS, whereas increasing clinician volume of PCI was
associated with signiﬁcantly increasing likelihood of stroke or death after CAS (OR, 1.025; 95% CI, 1.004-1.047; P[ .019).
Conclusions: The stroke and death rate for CAS to treat carotid stenosis is inversely affected by the number of CAS and
EVAR/TEVAR procedures performed by a clinician. In contrast, a high-volume experience with PCI is not associated
with improved outcomes after CAS. (J Vasc Surg 2014;60:70-6.)Prior studies across multiple specialties have demon-
strated improved clinical outcomes for surgeons per-
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://dx.doi.org/10.1016/j.jvs.2014.01.044vascular procedures, increasing surgeon volume has been
associated with improved outcomes for carotid endarterec-
tomy, elective open abdominal aortic aneurysm (AAA)
repair, open and endovascular repair of ruptured AAAs,
thoracoabdominal aortic aneurysm repair, and lower ex-
tremity bypass.1,2,9-14 Recent articles have reported that
clinician volume may also affect the outcomes for carotid
artery stenting (CAS).15-17
It has been postulated that the enhanced outcomes
associated with high surgeon volume are related to
improved patient selection, intraoperative decision making,
technical skills, and postoperative care that evolve from
increased experience with the index operation. Recog-
nizing that surgical skill sets may transfer between opera-
tions, we previously hypothesized that a high-volume
experience with operations requiring similar skill sets will
be associated with the same volume-related improvements
in outcomes provided by experience with the index opera-
tion. For example, a robust experience with open vascular
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outcomes than a high-volume experience with speciﬁc in-
dex open vascular operations. That hypothesis was
conﬁrmed in our prior study, in which we showed that a
surgeon’s composite volume of open vascular operationsd
not AAA volumedwas a key determinant of in-hospital
mortality for open AAA repair.18 However, whether this
concept may be extrapolated to endovascular therapies,
such as CAS, is not known.
For CAS, whether general “guidewire and catheter”
skills are sufﬁcient to yield optimal outcomes is not known.
This question is highly relevant to CAS because these pro-
cedures are performed by interventionalists from multiple
specialties, including vascular surgeons, neuroradiologists,
neurosurgeons, cardiologists, and interventional radiolo-
gists, with varying expertise with endovascular therapies
and different levels of experience in the management of ce-
rebrovascular disease. In the current study, we addressed
this question by examining the type of clinician volume
that inﬂuences the outcomes for CAS. Speciﬁcally, we
asked the question: Is a high-volume experience with
CAS required to optimize outcomes for CAS, or are other
types of endovascular volume sufﬁcient to provide accept-
able outcomes for CAS?
METHODS
Database. The Nationwide Inpatient Sample (NIS)
from the Healthcare Cost and Utilization Project was
analyzed to identify patients undergoing CAS for the years
2005 to 2009. Details of the NIS database are summarized
at http://www.hcup-us.ahrq.gov/nisoverview.jsp and in
our prior publications.18-20 Patient demographics, primary
and secondary diagnoses based on International Classiﬁca-
tion of Diseases, Ninth Revision, Clinical Modiﬁcation
(ICD-9-CM) diagnosis, procedure codes, and clinical out-
comes are provided in the NIS databases. Comorbid con-
ditions were summarized by calculating amodiﬁedCharlson
Comorbidity Index (CCI), as described previously.21,22
Deﬁnitions of teaching hospitals and urban vs rural hospi-
tal designation were previously provided.18 This study was
exempt from Institutional Review Board approval because
the NIS data are de-identiﬁed and available to the public.
Identiﬁcation of CAS cases. Elective CAS procedures
were identiﬁed using ICD-9-CM procedure code 00.63
after merging with ICD-9-CM diagnosis codes for carotid
stenosis (433.0, 433.1). The presence or absence of
neurologic symptoms before CAS was determined by
several criteria. Patients were considered symptomatic if the
hospital discharge included an ICD-9-CM diagnosis code
for unilateral or bilateral carotid artery occlusion or stenosis
with cerebral infarction (433.11, 433.31), transient cere-
bral ischemia (435.9), amaurosis fugax (362.34), or any
diagnosis code for late effects of cerebrovascular disease
(438.0-438.9). The latter category of codes includes
cognitive, speech, visual, or motor deﬁcits that may occur
as sequelae of a stroke.
Clinician volume. Three types of clinician-speciﬁc
endovascular volume were evaluated for their effect onthe outcomes for CAS: (1) volume of CAS procedures; (2)
volume of endovascular AAA repairs (EVARs) plus thoracic
endovascular aortic aneurysm repairs (TEVARs); and (3)
volume of percutaneous coronary interventions (PCIs).
The strategy for identifying CAS procedures was outlined
above. EVAR and TEVAR cases were identiﬁed using
ICD-9-CM procedure codes 39.71 and 39.73 (endovas-
cular implantation of a graft in abdominal and thoracic
aorta, respectively). PCIs were identiﬁed using ICD-9-CM
procedure codes 36.06-36.09. For analyses of clinician-
speciﬁc volume, clinicians’ experience and outcomes were
tracked using Healthcare Cost and Utilization Project
unique physician identiﬁcation numbers.
From the cohort undergoing CAS during the study
period, 40.8% were excluded from the current study
because the CAS procedure could not be linked to a spe-
ciﬁc clinician in the database. Annual clinician volume for
CAS, EVAR/TEVAR, and PCI were calculated using the
number of procedures performed by each clinician during
the study period divided by the number of years that the
clinician was included in the database. Clinicians were
ranked in increasing order of mean annual volumes and
then divided into three equal tertiles of volume. The low,
medium, and high tertiles of CAS volume were deﬁned
by <5, 5 to 15, and >15 CAS procedures per year, respec-
tively. The EVAR/TEVAR volume tertiles were deﬁned
by <5, 5 to 16, and >16 EVAR/TEVAR operations per
year, respectively. The PCI volume tertiles were deﬁned
by <6, 6 to 38, and >38 PCIs per year, respectively. Clini-
cians who performed at least one CAS during the study
period were included in the CAS volume analysis, even if
no EVAR/TEVAR operations or PCIs were performed.
Clinicians performing CAS, but not EVAR/TEVAR or
PCI, were excluded from the respective EVAR/TEVAR
and PCI volume analyses. Clinician specialty is not
included in the NIS databases.
Outcomes. The primary end point of the study was a
composite outcome of any in-hospital stroke or death after
CAS, abbreviated as “stroke/death.” In-hospital death was
determined directly from a variable present in the database.
In-hospital postoperative stroke was deﬁned from diag-
nostic and procedure ICD-9-CM codes present in the NIS.
A patient was considered to have had a stroke after CAS if
the ICD-9-CM diagnosis code 997.02 (postoperative
stroke) was present as any of the secondary diagnosis codes
(but not as the principal diagnosis) during the hospital
admission. In addition, discharge records with ICD-9-CM
procedure code 99.10 (injection or infusion of thrombo-
lytic agent) were also indicative of postoperative stroke, but
only if the day of the thrombolysis did not precede that of
the CAS procedure.
Statistical analysis. Univariate analyses were per-
formed to describe the patients undergoing CAS regarding
baseline characteristics. Categoric data were analyzed using
c2 and the Cochran-Armitage trend tests, as indicated.
Continuous data are reported as means with standard
deviation (SD) for normally distributed data and as me-
dians with interquartile range (IQR) for non-normally
Table I. Patient demographics and comorbidities
Characteristic
Patients,
No. (%) Pa
Gender <.0001
Male 4117 (60.3)
Female 2711 (39.7)
Age, years <.0001
0-44 80 (1.2)
45 64,1584 (23.4)
65-84 4686 (68.9)
$85 443 (6.5)
Race <.0001
White 5342 (78.6)
African American 218 (3.2)
Hispanic 254 (3.7)
Other 249 (3.8)
Unknown 730 (10.7)
Primary expected payer <.0001
Medicare/Medicaid 5113 (75.3)
Private insurance 1464 (21.5)
Self-pay/other 216 (3.2)
Comorbidities
Congestive heart failure 667 (9.8)
Hypertension 4965 (73.0)
Peripheral arterial disease 1728 (25.9)
Diabetes 1816 (26.6)
Chronic pulmonary disease 1372 (20.1)
Chronic renal failure 526 (7.7)
Myocardial infarction 758 (11.7)
Symptomatic cerebrovascular
disease
1106 (16.2)
Obesity 321 (4.7)
CCI score <.0001
0 14 (0.2)
1 2274 (33.3)
2 2315 (33.9)
$3 2226 (32.6)
Hospital type <.0001
Teaching 3947 (57.8)
Nonteaching 2881 (42.2)
Hospital location <.0001
Urban 6652 (96.1)
Rural 176 (3.9)
CCI, Charlson Comorbidity Index.
aDerived from c2 for equal proportions.
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SURVEYFREQ procedure in SAS 9.2 software (SAS
Institute Inc, Cary, NC) were performed to estimate the
number of CAS during the study period from the stratiﬁed
sampling provided by the NIS database. All the other an-
alyses were performed using the unweighted data.
Univariate analyses using Cochran-Armitage tests were
conducted to assess for signiﬁcant trends in the rates of
stroke and death across tertiles of clinician volume for
CAS, EVAR/TEVAR, and PCI. Multiple logistic regres-
sion analyses were used to examine the association between
clinician volume and the composite end point of in-hospital
stroke and death after CAS, adjusting for symptomatic sta-
tus, comorbidities, patient demographics, and hospital
characteristics. To account for the effects of different types
of clinician volume on outcomes, three different regression
models were created. Each model contained one of the
three variables of clinician volume: CAS, EVAR/TEVAR,
or PCI. In each model, clinician volume was analyzed as
a continuous variable. To determine if there was any inter-
action between the volume variables, we performed two
additional logistic regression models with interaction terms
for CAS volume with EVAR/TEVAR volume and CAS
volume with PCI volume. All analyses were two-tailed,
and the threshold for signiﬁcance was .05. Statistical anal-
ysis was performed using SAS 9.2 software.
RESULTS
During the 5-year study period, 11,535 elective CAS
procedures were identiﬁed from the NIS data sets. On
the basis of the 20% sampling strategy of the NIS database,
this projects to an estimated 56,374 elective CAS proce-
dures (95% conﬁdence interval [CI], 56,297-56,451) per-
formed nationwide between 2005 and 2009. Of those,
6828 records (59.2%) contained data on the surgeons per-
forming the procedures and were included in the analyses.
The excluded patients did not differ signiﬁcantly from the
study cohort in baseline demographics, comorbidities, pro-
portion of symptomatic patients, and in-hospital composite
stroke/death (data not shown).
The baseline demographics and comorbidities of the
cohort undergoing CAS are outlined in Table I. Most pa-
tients were men (60%) and non-Hispanic white (78.6%).
CAS procedures were performed more frequently in pa-
tients aged >65 years, and 16.2% of the cohort was treated
for symptomatic carotid stenosis. The number of CAS pro-
cedures performed nationwide signiﬁcantly increased from
5063 in 2005 to 6329 in 2009 (P < .0001 for trend).
The crude in-hospital composite stroke/death rate for
CAS was 3.22% (in-hospital stroke rate, 3.04%; in-hospital
mortality rate, 0.35%). As expected, patients with symp-
tomatic carotid stenoses, as deﬁned in Methods, had a
higher stroke/death rate (5.72%) than asymptomatic pa-
tients (2.74%; P < .0001). The incidence of in-hospital
stroke/death remained stable during the study period, at
3.05% in 2005 and 3.14% in 2009 (P ¼ .541 for trend).
Examined individually, stroke rates (2.94% in 2005 and
2.99% in 2009, P ¼ .499 for trend) and death rates(0.41% in 2005 and 0.22% in 2009; P ¼ .086 for trend)
did not vary signiﬁcantly across the study period.
The mean annual number of CAS procedures per-
formed per clinician was 14.8 procedures (range, 1-95;
SD, 16.8; median, 9; IQR, 3-20; mode, 1). Among clini-
cians who performed CAS and endovascular aortic repairs,
the mean annual number of EVARs and TEVARs was 16.9
operations (range, 1-94; SD, 20.9; median, 9; IQR, 4-21,
mode 1). The mean annual number of PCI procedures per
clinician was 43.4 (range, 1-723; SD, 65.9; median, 21;
IQR, 3-60; mode, 1).
The relationship between clinician volume and the
stroke/death rate varied according to the type of endovas-
cular volume examined. When clinician volume of CAS
procedures was stratiﬁed into tertiles, the composite
stroke/death rate for CAS decreased signiﬁcantly as the
number of CAS procedures performed annually increased
Fig. Relationship between the stroke/death rate (with 95% con-
ﬁdence intervals [CIs], range bars) for carotid artery stenting
(CAS) and different types of clinician volume was plotted for the
tertiles of (A) CAS volume, (B) endovascular aneurysm repair
(EVAR)/thoracic endovascular aortic repair (TEVAR) volume,
and (C) percutaneous coronary intervention (PCI) volume. A, A
signiﬁcant relationship was noted between CAS volume and the
stroke/death rate for CAS (P < .0001, Cochran-Armitage trend
test). B, A similar relationship was observed between EVAR/
TEVAR volume and the stroke/death rate for CAS (P ¼ .0023,
Cochran-Armitage trend test). C, No signiﬁcant relationship was
observed between PCI volume and outcomes for CAS (P ¼ .35,
Cochran-Armitage trend test).
Table II. In-hospital stroke/death rates by risk factor
Parameter Mortality rate, % Pa
Gender .069
Male 2.91
Female 3.70
Age, years .55
1-44 2.64
45-64 2.90
65-84 3.24
$85 4.27
Race <.0001
White 2.78
African American 5.46
Hispanic 8.02
Other 5.18
Symptomatic cerebrovascular disease <.0001
Absent 2.74
Present 5.72
CCI score <.0001
0 7.10
1 2.55
2 2.46
$3 4.68
Chronic lung disease .79
Absent 3.25
Present 3.11
Chronic renal failure .30
Absent 3.16
Present 4.00
Congestive heart failure .54
Absent 3.26
Present 2.83
Diabetes mellitus .30
Absent 3.36
Present 2.85
Obesity .33
Absent 3.18
Present 4.17
Hospital type .23
Teaching 3.45
Nonteaching 2.94
Hospital location <.0001
Urban 3.37
Rural 0
Primary expected payer .066
Medicare/Medicaid 3.27
Private insurance 3.07
Self-pay/other 3.26
CCI, Charlson Comorbidity Index.
aP values by c2 square.
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volume tertile (2.27%) was nearly half of that observed in
the low-volume tertile (4.43%). Similarly, the incidence
of stroke/death decreased signiﬁcantly as clinicians’ annualvolume of EVAR/TEVAR cases increased (Fig, B). In
contrast, clinician volume of PCIs did not affect the
stroke/death rate for CAS (Fig, C).
To identify other variables that may be related to the
risk of stroke/death for CAS, patients undergoing CAS
were stratiﬁed into groups by outcomes and compared
(Table II). Patients with stroke/death after CAS were
more likely to be of nonwhite race, treated in urban hospi-
tals, present with symptomatic carotid stenoses, and have
higher CCI scores. To identify independent predictors of
stroke/death after CAS, three stepwise logistic regression
models were created. Each model included one of the three
clinician volume variables (CAS, EVAR/TEVAR, or PCI
Table III. Independent predictors of stroke/death after
carotid artery stenting (CAS), including CAS volume
Predictor OR (95% CI)a P
CAS volume per 10 cases 0.84 (0.74-0.94) .0037
Age per 10 years 1.26 (1.08-1.47) .0033
Race 1.27 (1.13-1.41) <.0001
Symptomatic carotid stenosis 2.16 (1.57-2.97) <.0001
CCI 1.24 (1.13-1.36) <.0001
Hospital size 1.37 (0.99-1.92) <.0078
CCI, Charlson Comorbidity Index; CI, conﬁdence interval; OR, odds ratio.
aOR of in-hospital stroke or death after CAS.
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ables that were signiﬁcant on univariate analysis (Table II).
These regression models showed that increasing clini-
cian volume of CAS or EVAR/TEVAR, but not PCI,
was associated with decreasing odds of stroke/death. For
each 10-case increase in volume of CAS procedures per-
formed by a clinician, the stroke/death rate decreased
by 16% (odds ratio [OR], 0.84; 95% CI, 0.74-0.94;
P ¼ .003; Table III). In addition to clinician volume of
CAS, regression analysis found that increasing age,
nonwhite race, symptomatic carotid stenosis, increasing
CCI, and smaller hospital size were signiﬁcant predictors
of stroke/death after CAS. All of these variables increased
the risk of stroke/death, whereas increasing CAS volume
decreased the risk of this end point.
Similarly, an increasing volume of EVAR/TEVAR pro-
cedures performed by the clinician decreased the risk of
stroke/death after CAS. For every 10-case increase in the
EVAR/TEVAR volume, the likelihood of stroke/death af-
ter CAS decreased by 15% (OR, 0.85; 95% CI, 0.75-0.97;
P ¼ .020). In contrast, increasing volume of PCI proce-
dures was associated with a higher probability of stroke/
death after CAS (OR, 1.025 per 10 PCI procedures; 95%
CI, 1.004-1.047; P ¼ .019). Regression models including
multiple volume variables conﬁrmed that there was no sig-
niﬁcant interaction between CAS volume and EVAR/
TEVAR volume (P ¼ .17) and between CAS volume and
PCI volume (P ¼ .92) in inﬂuencing outcomes.
DISCUSSION
The current study demonstrated that a high-volume
experience with CAS or EVAR/TEVAR is associated
with a lower risk of stroke/death for CAS. The ﬁnding
that a high-volume experience with PCI does not offer
the same protection from adverse outcomes suggests that
endovascular skills alone are not sufﬁcient to optimize the
outcomes for CAS. In addition to the technical skills neces-
sary to perform CAS, we surmise that the procedure has a
cognitive component that is essential to achieving optimal
outcomes. For instance, patient selection and intraopera-
tive decision making are critical elements of successfully
performing any procedure, especially for procedures that
carry a signiﬁcant risk of adverse outcomes. The multispe-
cialty consensus statement on training and credentialing for
CAS qualiﬁcations stated that physicians who wish to
perform CAS should be required to have the “cognitive,
technical, and clinical skills necessary to care for patients
with carotid artery disease.”23 A high-volume experience
with CAS affords clinicians the opportunity to reﬁne each
of these skills, which translates into lower stroke/death
rates for CAS.
The mechanism by which a high-volume experience
with EVAR/TEVAR facilitates favorable outcomes for
CAS is less obvious. Because many clinicians who perform
EVARs and TEVARs are vascular surgeons, we speculate
that experience in the management of cerebrovascular dis-
ease among vascular surgeons facilitates patient selection
and intraoperative decision making for CAS. In contrast,we suspect that most clinicians who perform PCI may
have limited experience managing cerebrovascular disease
because of their specialty training and the case-mix in their
practices. Insufﬁcient experience managing cerebrovascular
disease could have implications for patient selection and
intraoperative decision making for CAS. It is important
to acknowledge, though, that the data in the current study
cannot directly address the reasons why increasing PCI vol-
ume does not translate into improved outcomes for CAS.
Future studies should endeavor to answer this question
because this issue could inﬂuence training and credential-
ing paradigms related to CAS.
Although our results showed that a high-volume expe-
rience with EVAR/TEVAR yielded favorable results for
CAS, we believe that direct experience with CAS is critical
to obtaining a favorable stroke/death rate for CAS, regard-
less of training background. The data from the current
study may be an indication that certain individuals will
require a shorter learning curve before optimal results
with CAS can be obtained. Deﬁning the optimal mix of
technical skills and cognitive experience that will yield the
best results for CAS would be helpful to guide training
and credentialing paradigms in a manner that is linked
directly to patient outcomes. Until the critical elements
necessary for optimal outcomes are deﬁned, however,
concluding that clinicians who perform PCI should not
be performing CAS would be premature and inappropriate.
Our data merely suggest that there are additional skill sets,
aside from technical skills, that must be acquired to mini-
mize the risk of adverse outcomes with CAS.
The results of the current study could be interpreted as
contradicting our prior study on the type of surgeon vol-
ume that affects the outcomes for open AAA repair. That
study showed a surgeon’s overall experience with similar
operations (“composite volume”), rather than direct expe-
rience with an index operation (“operation-speciﬁc vol-
ume”), inﬂuenced the outcomes for open AAA repair.18
We believe that the two studies can be reconciled.
Taken together, we interpret these studies as suggesting
that there are some operations for which general skill sets
(open or endovascular skills) are sufﬁcient to achieve
acceptable outcomes, whereas a minority of operations,
especially complex operations with a high risk of adverse
outcomes, requires direct experience to acquire the skills
sets necessary to achieve the best outcomes. Potential
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dure-speciﬁc experience is necessary would be fenestrated
EVAR and open thoracic AAA repair.
The current study conﬁrms and expands prior studies
that described a relationship between operator volume
and outcomes for CAS.15-17 In a postmarket study of a ca-
rotid stent and embolic protection system, the Carotid
ACCULINK/ACCUNET Post Approval Trial to Uncover
Rare Events (CAPTURE 2) study found that the stroke
and death rate for CAS was inversely related to clinician
volume.15 Using the NIS database for the years 2005
and 2006, Vogel et al16 found that the stroke rate after
CAS was 2.19% for low-volume practitioners vs 1.51% for
high-high-volume practitioners, which was signiﬁcantly
different. In the current study, we extended those observa-
tions by determining whether other types of endovascular
volume similarly inﬂuence the outcomes for CAS.
The current study has limitations that must be
acknowledged. First, the current study offers insights into
the types of volume that affect the outcomes for CAS,
but whether these data can be extrapolated to other open
or endovascular operations is not known.
Second, the current study was unable to address the
role of prior experience on outcomes. Presumably, there
are a threshold number of procedures after which a clini-
cian requires little ongoing experience to achieve excellent
results.
Third, administrative databases, such as the NIS
database, are admittedly imperfect. Hertzer24 expressed
concerns about the NIS database for investigations related
to carotid interventions because prior reports using the NIS
reported a lower stroke rate for CAS of 1.3% to 1.9%
than the 30-day rate of 2.5% reported in the Carotid
Revascularization Endarterectomy vs Stenting Trial
(CREST), despite the careful vetting of interventionalists
in CREST.24-30 Hertzer interpreted the discrepant stroke
rates as potential evidence of “inadequate documentation
of preprocedural symptoms and periprocedural strokes in
the medical records, leading to subsequent coding errors
in the hospital discharge abstracts from which NIS data
are extracted.”24 However, the stroke rate in the current
study was 3.04%, which is comparable to the stroke rate re-
ported in CREST.25 We believe that the congruence of
stroke rates between the current study and CREST offers
some reassurance that our strategy for identifying CAS
cases resolved the potential concerns raised by Hertzer.
An additional concern with the NIS database is the lack
of anatomic data in the NIS to ascertain the contribution
of carotid anatomy and lesion characteristics to outcomes.
Finally, 40% of CAS procedures identiﬁed from the
NIS databases could not be attributed to individual opera-
tors and were excluded for that reason. Because the demo-
graphics, symptomatic status, and outcomes for the
excluded patients were no different from the study cohort,
we do not believe that the high proportion of excluded pa-
tients adversely affected the study.
Despite these limitations, the numbers of patients in
the NIS database offered a unique opportunity to examinethe relationship between clinician volume and outcomes
for procedures such as CAS.
CONCLUSIONS
The stroke/death rate for CAS is inversely related to
the number of CAS and EVAR/TEVAR procedures per-
formed by a clinician. In contrast, increasing clinician vol-
ume of PCI is not associated with improved outcomes
after CAS. These data suggest that endovascular skills alone
are not sufﬁcient to achieve optimal results for CAS. The
type of additional skill sets necessary to obtain favorable
outcomes for CAS are not known, but we believe that clin-
ical outcomes for carotid stenting are inﬂuenced by a
cognitive component.
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patients, 2004 to 2005. J Vasc Surg 2011;53:1457-65.Submitted Sep 22, 2013; accepted Jan 20, 2014.INVITED COMMENTARYKeith D. Calligaro, MD, Philadelphia, PaWe know that high clinician volume of carotid artery stenting
(CAS) is associated with low rates of complications of this proce-
dure. Similarly, one would think that high clinician volume of
other endovascular procedures might translate into low rates of
complications of CAS. However, why should a low CAS complica-
tion rate be associated with high clinician volume of aortic endog-
rafting but not with high clinician volume of coronary stenting, as
reported in this article? After all, don’t both CAS and coronary
stenting require high levels of expertise and skill?
The authors surmise that in addition to the technical skills
necessary to perform CAS, a “cognitive component” of the proce-
dure is essential to achieving optimal outcomes. The authors quote
the multispecialty consensus statement on training and credential-
ing for CAS qualiﬁcations: “physicians who wish to perform
carotid stenting should be required to have the cognitive, tech-
nical, and clinical skills necessary to care for patients with carotid
artery disease.”
Cardiologists might interpret the authors’ comments as sug-
gesting that they have lower IQs than vascular surgeons. However,
the authors are actually proposing that insufﬁcient experience in
managing cerebrovascular disease on the part of cardiologists could
have implications for patient selection and intraoperative decision-
making for CAS.On the one hand, instead of disparaging this article, cardiolo-
gists might consider these ﬁndings as being important for their
training programs. If other studies support this one and show
that high volume of interventional cardiology procedures does
not translate into low complication rates of CAS, then cardiology
program directors should consider increasing their trainee’s expo-
sure to management of cerebrovascular disease if they wish to
produce CAS specialists.
On the other hand, the authors of this article suggest that a
high clinician volume of aortic endografting (which is primarily
performed by vascular surgeons) may be a substitute for CAS
stenting experience before achieving low complication rates of
this procedure, whereas a high clinician volume of coronary stent-
ing (primarily performed by cardiologists) is not an adequate
substitute for CAS stenting experience. Cardiologists may interpret
this point of view as being self-serving because numerous reports
have shown that cardiologists can perform CAS with very low
complication rates. In the future, if an article written by cardiolo-
gists shows that vascular surgeons who perform a high volume of
endovascular procedures for lower-extremity occlusive disease
have higher rates of CAS complications than those who perform
low-volume endovascular procedures for lower-extremity occlusive
disease, would vascular surgeons believe it?
